Inventor

BILODEAU MARK T

US60 patents

⚠️ This page may combine multiple inventors who share the name “BILODEAU MARK T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BILODEAU MARK T

MERCK & CO INC

Tyrosine kinase inhibitors

Tyrosine kinase inhibitors

(5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors

Tyrosine kinase inhibitors

Tyrosine kinase inhibitors

Tyrosine kinase inhibitors

Substituted imidazoles having cytokine inhibitory activity

Tyrosine kinase inhibitors

Tyrosine kinase inhibitors

Tyrosine kinase inhibitors

Angiogenesis inhibitors

Angiogenesis inhibitors

Inhibitors of Akt activity

Angiogenesis inhibitors

Inhibitors of Akt activity

Tyrosine kinase inhibitors

Inhibitors of Akt activity

Tyrosine kinase inhibitors

Inhibitors of Akt activity

Inhibitors of Akt activity

Polymorphs with tyrosine kinase activity

PLACON THERAPEUTICS INC

Platinum compounds, compositions, and uses thereof

Compounds, compositions, and methods for the treatment of cancers

Platinum compounds, compositions, and uses thereof

Platinum compounds, compositions, and uses thereof

Compounds, compositions, and methods for the treatment of cancers

Compounds, compositions, and methods for the treatment of cancers

Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof

Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof

Compounds, compositions, and methods for the treatment of cancers

MERCK SHARP & DOHME

Inhibitors of Akt activity

Inhibitors of Akt activity

Inhibitors of Akt activity

Inhibitors of Akt activity

Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds

Potassium channel inhibitors

TARVEDA THERAPEUTICS INC

Targeted conjugates and particles and formulations thereof

Targeted conjugates and particles and formulations thereof

Targeted conjugates and particles and formulations thereof

HSP90 targeted conjugates and particles and formulations thereof

SSTR-targeted conjugates and particles and formulations thereof

HSP90-targeting conjugates and formulations thereof

BILODEAU MARK T

Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds

Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds

TRPA1 antagonists

SLOAN KETTERING INST CANCER

Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof

Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof

TVA ABC LLC

HSP90 targeted conjugates and particles and formulations thereof

Targeted conjugates and particles and formulations thereof

ALTMAN MICHAEL D

Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitors